Pharmaceutical Sector

Glenmark Generics Launches ‘Perindopril’ In UK

Glenmark Generics Ltd, a division of drug maker Glenmark Pharmaceuticals Ltd, has made announcement about the launching of its anti-hypertension drug ‘Perindopril’ in the UK market.

U.S. Supreme Court to Decide Drug Liability Case

Lawyers for drug maker Wyeth and the Bush administration told the U.S. Supreme Court that according to a federal law pharmaceutical companies are not liable for harm from medicines that meet the standards set by the Food and Drug Administration and used as the label indicates.

Sun’s US subsidiary Caraco issued warning letter by FDA

Caraco Pharmaceutical Laboratories, the Detroit-based generic subsidiary of Sun Pharmaceuticals Ltd., has been issued a letter of warning by the US Food and Drug Administration (FDA), and all its future marketing approvals for medicines have been withheld due to some quality-control issues.

This action of the US regulator comes in the wake of certain technical inadequacies identified by it during a May 2008 inspection. The FDA considered some of its observations to be repeat observations, and hence issued the warning letter.

Caraco said the FDA observations include, among other things, the inadequate and untimely investigation by the quality control unit of certain incidents at the facility contrary to the company’s standard operating procedures.

Genentech seeks Avastin approval for brain cancer

Genentech seeks Avastin approval for brain cancer

Sun’s US subsidiary Caraco issued warning letter by FDA

Sun’s US subsidiary Caraco issued warning letter by FDACaraco Pharmaceutical Laboratories, the Detroit-based generic subsidiary of Sun Pharmaceuticals Ltd., has been issued a letter of warning by the US Food and Drug Administration (FDA), and all its future marketing approvals for medicines have been withheld due to some quality-control issues.

This action of the US regulator comes in the wake of certain technical inadequacies identified by it during a May 2008 inspection. The FDA considered some of its observations to be repeat observations, and hence issued the warning letter.

Consumer Group calls for ban on Avandia, GlaxoSmithKline’s Diabetes Drug

GlaxoSmithKlineGlaxoSmithKline P. L. C.'s drug Avandia is facing flak for causing more than one dozen cases of liver failure and death in patients taking the drug according to a consumer advocacy group Public Citizen.

Pages